Venus Remedies is a research-driven Indian pharmaceutical company committed to advancing global health through innovative, affordable medicines. Established in 1989, it specializes in injectable formulations and critical-care drugs including antibiotics, oncology, neurology, and pain management, while maintaining a robust pipeline addressing antimicrobial resistance. The company operates internationally with over 1,040 marketing authorizations and a broad portfolio of therapies and treatments. With state-of-the-art manufacturing and research facilities, Venus Remedies aims to improve patient outcomes worldwide.